메뉴 건너뛰기
Thrombosis and Haemostasis
Volumn 102, Issue 3, 2009, Pages 609-610
Species-dependent molecular drug targets in plasminogen activator inhibitor-1 (PAI-1)
Author keywords

[No Author keywords available]
Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 159M12; MONOCLONAL ANTIBODY 31C9; PLASMINOGEN ACTIVATOR INHIBITOR 1; UNCLASSIFIED DRUG;
EID: 70449366406     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-04-0257     Document Type: Letter
Times cited : (7)
References (6)
  • 1
    • 18844375381 scopus 로고    scopus 로고
    • Pleiotropic functions of plasminogen activator inhibitor-1
    • DOI 10.1111/j.1538-7836.2004.00827.x
    • Lijnen HR. Pleiotropic functions of plasminogen activator inhibitor-1. J Thromb Haemost 2005; 3: 35-45. (Pubitemid 41647113)
    • (2005) Journal of Thrombosis and Haemostasis , vol.3 , Issue.1 , pp. 35-45
    • Lijnen, H.R.1
  • 2
    • 49849096654 scopus 로고    scopus 로고
    • Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist, in a rat model of thrombosis
    • Hennan JK, Morgan GA, Swillo RE, et al. Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist, in a rat model of thrombosis. J Thromb Haemost 2008; 6: 1558-1564.
    • (2008) J Thromb Haemost , vol.6 , pp. 1558-1564
    • Hennan, J.K.1    Morgan, G.A.2    Swillo, R.E.3
  • 3
    • 48949116914 scopus 로고    scopus 로고
    • The effects of pharmacological PAI-1 inhibition on thrombus formation and neointima formation after arterial injury
    • DOI 10.1517/14728222.12.7.783
    • Suzuki J, Ogawa M, Muto S, et al. The effects of pharmacological PAI-1 inhibition on thrombus formation and neointima formation after arterial injury. Expert Opin Ther Targets 2008;12: 783-794. (Pubitemid 352003320)
    • (2008) Expert Opinion on Therapeutic Targets , vol.12 , Issue.7 , pp. 783-794
    • Suzuki, J.-I.1    Ogawa, M.2    Muto, S.3    Yamaguchi, Y.4    Itai, A.5    Isobe, M.6
  • 4
    • 1342303482 scopus 로고    scopus 로고
    • Of Mice and Not Men: Differences between Mouse and Human Immunology
    • Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol 2004; 172: 2731-2738. (Pubitemid 38263654)
    • (2004) Journal of Immunology , vol.172 , Issue.5 , pp. 2731-2738
    • Mestas, J.1    Hughes, C.C.W.2
  • 5
    • 1642318429 scopus 로고    scopus 로고
    • The structural basis for the pathophysiological relevance of PAI-1 in cardiovascular diseases and the development of potential PAI-1 inhibitors
    • Gils A, Declerck PJ. The structural basis for the pathophysiological relevance of PAI-I in cardiovascular diseases and the development of potential PAI-I inhibitors. Thromb Haemost 2004; 91: 425-437. (Pubitemid 38396864)
    • (2004) Thrombosis and Haemostasis , vol.91 , Issue.3 , pp. 425-437
    • Gils, A.1    Declerck, P.J.2
  • 6
    • 0036336458 scopus 로고    scopus 로고
    • Importance of N-terminal residues in plasminogen activator inhibitor 1 on its antibody induced latency transition
    • Ngo TH, Zhou Y, Stassen JM, et al. Importance of N-terminal residues in plasminogen activator inhibitor 1 on its antibody induced latency transition. Thromb Haemost 2002; 88: 288-293. (Pubitemid 34873711)
    • (2002) Thrombosis and Haemostasis , vol.88 , Issue.2 , pp. 288-293
    • Ngo, T.-H.1    Zhou, Y.2    Stassen, J.-M.3    Declerck, P.J.4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.